Intriguingly, immunohistochemical staining showed that MARK3 was strongly detected in the cell membrane and cytoplasm of HFTSECs, and STICs; however, its presence was diminished in primary HGSOCs, suggesting that the expression of MARK3 was repressed at a later stage of cancer development. Here, MARK3 is linked to cancer.